CXCR4 and adrenal cortex carcinoma: Two of these radioligands, 64Cu-plerixafor and 68Ga-Pentixafor, can also reliably assess the expression of CXCR4 in vivo in patients affected by ACC or aldosterone producing adenoma, respectively (4, 38).